0001667699-16-000004.txt : 20160412 0001667699-16-000004.hdr.sgml : 20160412 20160412164138 ACCESSION NUMBER: 0001667699-16-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160412 DATE AS OF CHANGE: 20160412 EFFECTIVENESS DATE: 20160412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Renibus Therapeutics, Inc. CENTRAL INDEX KEY: 0001667699 IRS NUMBER: 810872431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258033 FILM NUMBER: 161567624 BUSINESS ADDRESS: STREET 1: 727 LATHROP STREET CITY: LANTANA STATE: TX ZIP: 76226 BUSINESS PHONE: 469-688-3174 MAIL ADDRESS: STREET 1: 727 LATHROP STREET CITY: LANTANA STATE: TX ZIP: 76226 D/A 1 primary_doc.xml X0707 D/A LIVE 0001667699 Renibus Therapeutics, Inc. 727 LATHROP STREET LANTANA TX TEXAS 76226 469-688-3174 DELAWARE None None Corporation true 2015 Harpreet Kaur 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Director Chairman of the Board, Chief Executive Officer and President Carlos Guillem 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Director Secretary Dale Jones 727 Lathrop Street Lantana TX TEXAS 76226 Director Jennifer D. Rasmussen 727 Lathrop Street Lantana TX TEXAS 76226 Director Jocelyn Keyser 727 Lathrop Street Lantana TX TEXAS 76226 Director Nels Bergmark 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Treasurer Pharmaceuticals Decline to Disclose 06b true 0001667699-16-000003 2016-02-10 false true false 0 12500000 10204000 2296000 false 101 0 0 0 false Renibus Therapeutics, Inc. /s/ Harpreet Kaur Harpreet Kaur Chairman of the Board, CEO and President 2016-04-12